Form 8-K - Current report:
SEC Accession No. 0001213900-24-078294
Filing Date
2024-09-13
Accepted
2024-09-13 08:53:18
Documents
15
Period of Report
2024-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214462-8k_allarity.htm   iXBRL 8-K 39254
2 SECOND AMENDMENT TO AT-THE-MARKET ISSUANCE SALES AGREEMENT, DATED SEPTEMBER 9, 2 ea021446201ex10-1_allarity.htm EX-10.1 7217
3 EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 12, 2024, BY AND BETWEEN ALLARITY TH ea021446201ex10-2_allarity.htm EX-10.2 120227
  Complete submission text file 0001213900-24-078294.txt   375399

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE allr-20240909.xsd EX-101.SCH 3015
5 XBRL LABEL FILE allr-20240909_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE allr-20240909_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0214462-8k_allarity_htm.xml XML 3798
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 241296536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)